Andrea Baccarelli

Dean of the Faculty

Columbia University Mailman School of Public Health
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Background The role of adipokines in childhood glycemia is poorly understood. We investigate the longitudinal association between adipokines and glycemia in a cohort of children in Mexico City. Methods Children from the Programming Research in Obesity, Growth, Environment, and Social Stressors (PROGRESS) cohort (948 children, 52% male) were followed longitudinally from birth. Leptin, adiponectin, glucose, and HbA 1c were measured at four, six, and eight years, and fasting insulin at eight years. Adiponectin to leptin ratio (ALR) and HOMA2 indices were computed. Longitudinal associations were examined by linear mixed models and cross-sectional associations were examined by multivariable linear regression. All models were adjusted for maternal and child covariates. Findings Between ages four and eight years, average levels of leptin increased from 3·2 to 10·8 ug/mL; adiponectin dropped from 15·7 to 13·7 ng/mL; and ALR dropped from 9·1 to 3·1 ug/ng. Longitudinally, across timepoints four, six, and eight years after birth, there was no association between adipokines and glycemia. However, the cross-sectional analysis at age 8 years found an association between leptin and insulin (1·0, 95% CI: 1·0; 1·1), HOMA2-B (1·0, 95% CI: 1·0; 1·0), HOMA2-IR (1·0, 95% CI: 1·0; 1·1), and HOMA2-S (0·9, 95% CI: 0·9; 0·9). Interpretation Further investigation is needed to understand the role of adipokines in the development of T2DM in children and the factors that may alter adipokine metabolism.

Year:

2026

Wellbeing is associated with both behavioral phenotypes as well as several key life outcomes, such as health, employment, and coping with stressful events. These phenotypes associated with wellbeing could be potential indicators of differential epigenetic patterns between individuals that differ in their levels of wellbeing. We performed the largest epigenome-wide (EWAS) meta-analysis of wellbeing to date by combining whole blood DNA methylation data (Illumina 450k array) from 13 cohorts from Europe, Australia, and the USA ( N = 10,757 participants). After correcting for smoking and BMI, no epigenome-wide significant methylation sites were identified. We tested whether a weighted methylation score (MS) based on leave-one-cohort-out EWAS meta-analysis summary statistics predicted wellbeing in an independent cohort, and whether prediction was significant over and above the polygenic score (PGS) for wellbeing. The MS was associated with wellbeing (variance explained=0.22%, p =0.03) and was no longer significant after adding the polygenic score (PGS; variance explained=0.43%, p =0.0046, MS; variance explained=0.07%, p =0.2842). We further compared DNA methylation levels in 16 pairs of monozygotic twins discordant for wellbeing. These analyses revealed no significant within-pair DNA methylation differences at the top-sites from the meta-analysis or in MS. Our results suggest that larger EWAS meta-analyses with uniform phenotype assessment are required to identify methylation sites associated with wellbeing.

Year:

2025

Collaborators (22)

Lude Franke

University Medical Center Groningen

NETHERLANDS
View details

Marian Bakermans-Kranenburg

Professor

-

PORTUGAL
View details

Allan F McRae

The University of Queensland Queensland Brain Institute

AUSTRALIA
View details

Matthew Suderman

Academic , Associate Professor in Molecular Epidemiology

University of Bristol

UNITED KINGDOM
View details

Kaare Christensen

University of Southern Denmark

DENMARK
View details

Margot van de Weijer

University of Amsterdam

NETHERLANDS
View details

Manoj Bhasin

Director, Genomics, Proteomics, Bioinformatics and Single cell Biology

Children's Healthcare of Atlanta

UNITED STATES
View details

Jadwiga Buchwald

University of Helsinki

FINLAND
View details

Miina Ollikainen

University of Helsinki

FINLAND
View details

Avron Spiro III

Research Professor

boston university chobanian and avedisian school of medicine

UNITED STATES
View details

Jenny van Dongen

University of Amsterdam

NETHERLANDS
View details

Henning Tiemeier

Professor of Maternal and Child Health

Harvard T.H. Chan School of Public Health

UNITED STATES
View details

Usha Ramakrishnan

Professor and Chair

Emory University

UNITED STATES
View details

Yara Beyh

Emory University

UNITED STATES
View details

Maayan Yitshak-Sade

Associate Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Meike Bartels

Professor in Genetics and Wellbeing

Vrije Universiteit Amsterdam

NETHERLANDS
View details

Birgit Debrabant

University of Southern Denmark

DENMARK
View details

Ian Deary

University of Edinburgh

UNITED KINGDOM
View details

Janine F. Felix

-

NETHERLANDS
View details

Estelle Lowry

The Queen's University Belfast

UNITED KINGDOM
View details

Jaakko Kaprio

Research Director

University of Helsinki

FINLAND
View details

Michelle Luciano

University of Edinburgh

UNITED KINGDOM
View details